ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,542Medicare Part D Prescriptions Filled, Including Refills

Rank: 228 out of 2588

$703K Total Retail Price of All Prescriptions

Rank: 230 out of 2588

813 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 813 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 11,601 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 538 479 1 1
LEVOTHYROXINE SODIUM 538 498 1 2
OMEPRAZOLE 485 450 3 6
LOSARTAN POTASSIUM 441 427 4 17
LISINOPRIL 380 322 5 3
HYDROCHLOROTHIAZIDE 341 326 6 13
METOPROLOL TARTRATE 340 305 7 9
HYDROCODONE-ACETAMINOPHEN 325 242 S3 8 7
AMLODIPINE BESYLATE 321 294 9 4
FUROSEMIDE 315 309 10 5
ATENOLOL 306 285 11 14
CRESTOR 294 272 12 25
WARFARIN SODIUM 256 249 13 10
METOPROLOL SUCCINATE 254 240 14 12
TAMSULOSIN HCL 202 197 15 23
METFORMIN HCL 198 170 16 8
CITALOPRAM HBR 183 171 17 27
TRAMADOL HCL 180 164 18 19
ATORVASTATIN CALCIUM 172 137 19 11
ALLOPURINOL 167 163 20 33
PANTOPRAZOLE SODIUM 144 143 21 28
POTASSIUM CHLORIDE 144 143 21 15
DIGOXIN 143 143 23 38
CLOPIDOGREL 139 138 24 30
ZOLPIDEM TARTRATE 134 119 25 24
FENOFIBRATE 128 106 26 64
ISOSORBIDE MONONITRATE ER 120 117 27 49
KLOR-CON 10 120 107 27 75
METFORMIN HCL ER 119 117 29 67
DONEPEZIL HCL 112 112 30 22
GABAPENTIN 105 96 31 18
PRAVASTATIN SODIUM 104 101 32 16
PLAVIX 97 97 33 43
DIOVAN 96 94 34 29
BENICAR 91 85 35 143
LOVASTATIN 78 74 36 34
ALENDRONATE SODIUM 77 77 37 21
NAMENDA 75 75 38 32
AZITHROMYCIN 72 62 39 45
ONGLYZA 71 65 40 248
CLONIDINE HCL 69 65 41 54
ROPINIROLE HCL 69 63 41 113
GLYBURIDE 68 57 R 43 65
HYDRALAZINE HCL 68 64 43 53
FELODIPINE ER 67 65 45 108
RANITIDINE HCL 59 59 46 37
FINASTERIDE 57 57 47 97
ZETIA 54 51 48 69
DOXAZOSIN MESYLATE 54 54 48 96
CIPROFLOXACIN HCL 53 51 50 82
ENALAPRIL MALEATE 53 53 50 31
MELOXICAM 52 52 52 51
FAMOTIDINE 51 50 53 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.